KR101125482B1 - Composition for preventing and treating nose disease comprising extract of Star anis and aroma oil as active ingredients - Google Patents
Composition for preventing and treating nose disease comprising extract of Star anis and aroma oil as active ingredients Download PDFInfo
- Publication number
- KR101125482B1 KR101125482B1 KR1020090107319A KR20090107319A KR101125482B1 KR 101125482 B1 KR101125482 B1 KR 101125482B1 KR 1020090107319 A KR1020090107319 A KR 1020090107319A KR 20090107319 A KR20090107319 A KR 20090107319A KR 101125482 B1 KR101125482 B1 KR 101125482B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- oil
- composition
- antimicrobial
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 239000000284 extract Substances 0.000 title claims abstract description 12
- 208000030880 Nose disease Diseases 0.000 title claims abstract description 11
- 239000004480 active ingredient Substances 0.000 title abstract description 4
- 208000026344 Nasal disease Diseases 0.000 title abstract description 3
- 240000004760 Pimpinella anisum Species 0.000 title description 2
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 16
- 206010039083 rhinitis Diseases 0.000 claims abstract description 13
- 206010028735 Nasal congestion Diseases 0.000 claims abstract description 12
- 239000010692 aromatic oil Substances 0.000 claims abstract description 11
- 125000003118 aryl group Chemical group 0.000 claims abstract description 11
- 206010041235 Snoring Diseases 0.000 claims abstract description 8
- 239000007921 spray Substances 0.000 claims description 8
- 240000002045 Guettarda speciosa Species 0.000 claims description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 7
- 235000019501 Lemon oil Nutrition 0.000 claims description 7
- 239000010642 eucalyptus oil Substances 0.000 claims description 7
- 229940044949 eucalyptus oil Drugs 0.000 claims description 7
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 7
- 239000010501 lemon oil Substances 0.000 claims description 7
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 7
- 235000019477 peppermint oil Nutrition 0.000 claims description 7
- 239000010677 tea tree oil Substances 0.000 claims description 7
- 229940111630 tea tree oil Drugs 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 235000011511 Diospyros Nutrition 0.000 claims description 3
- 244000236655 Diospyros kaki Species 0.000 claims description 3
- 235000014347 soups Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 208000023504 respiratory system disease Diseases 0.000 abstract description 11
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 230000000241 respiratory effect Effects 0.000 abstract description 5
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 210000000056 organ Anatomy 0.000 abstract description 4
- 239000003205 fragrance Substances 0.000 abstract description 3
- 239000012676 herbal extract Substances 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 239000000419 plant extract Substances 0.000 abstract description 3
- 238000005507 spraying Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 10
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000001949 Taraxacum officinale Species 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000245665 Taraxacum Species 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- NBHKOXMOIRGJAI-UHFFFAOYSA-N 1-phenylbut-2-yne-1,4-diol Chemical compound OCC#CC(O)C1=CC=CC=C1 NBHKOXMOIRGJAI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- -1 n-nucleic acid Chemical compound 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940061367 tamiflu Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Abstract
본 발명은 동 서양의 식물추출물을 다수 포함하는 항균성과 호흡기질환에 효과를 가진 흡입성 천연 방향물질에 관한 것으로, 보다 상세하게는 팔각의 추출물과 다양한 한방재료추출물 및 여러 가지 천연 아로마 오일을 배합한 혼합물을 유효성분으로 포함하는 비강질환 예방 및 치료용 조성물 및 항균용 조성물에 관한 것이다. 본 발명의 조성물은 미생물로 부터 호흡기를 보호하고 코막힘과 코콜이 비염의 호흡질환을 호전시키고 머리를 맑게 하는 최적의 항균성 천연 방향 한방아로마 물질로, 본 발명은 팔각과 방향 한방재료들, 아로마오일을 적절히 배합하여 스프레이 등으로 흡입하여 사용함으로서 그 향취로 인한 상쾌함과 함께 항균작용, 코막힘, 코골이, 비염의 각종 호흡질환의 개선으로 효용성이 매우 높다고 하겠다.The present invention relates to an inhalable natural fragrance having an effect on the antimicrobial and respiratory diseases including a large number of plant extracts of the East and West, and more specifically, to the octagonal extract, various herbal extracts and various natural aromatic oils. It relates to a composition for preventing and treating nasal diseases and an antimicrobial composition comprising a mixture as an active ingredient. The composition of the present invention is an optimal antimicrobial natural aromatic herbal aroma material that protects the respiratory organs from microorganisms and prevents nasal congestion and kokol improves respiratory diseases of rhinitis and clears the head. Inhaled by spraying, etc., if properly mixed, the freshness of the odor and antimicrobial action, nasal congestion, snoring, rhinitis, various respiratory diseases to improve the effectiveness is very high.
팔각, 아로마, 비강질환, 비염, 항균 Octagonal, Aroma, Nasal Disease, Rhinitis, Antibacterial
Description
본 발명은 본 발명은 동 서양의 식물추출물을 다수 포함하는 항균성과 호흡기질환에 효과를 가진 흡입성 천연 방향물질에 관한 것으로, 보다 상세하게는 팔각의 추출물과 다양한 한방재료추출물 및 여러 가지 천연 아로마 오일을 배합한 혼합물을 유효성분으로 포함하는 비강질환 예방 및 치료용 조성물 및 항균용 조성물에 관한 것이다.The present invention relates to an inhalable natural aromatic substance having an effect on the antimicrobial and respiratory diseases including a large number of plant extracts of the East and the West, and more particularly, the extract of Octagon and various herbal ingredients and various natural aromatic oils. It relates to a composition for preventing and treating nasal diseases and an antimicrobial composition comprising a mixture containing the compound as an active ingredient.
사람의 코는 하루에 10,000~20,000리터의 공기를 조절하며 수많은 감염체, 항원, 독성물질을 여과하고 소멸시킨다. 또한 코는 매우 예민한 부위이므로 여러 가지 원인으로 인해 쉽게 코가 막힌다. 이런 경우 머리에 산소 공급이 원활히 되지 않아 두뇌에 지장을 주며, 신경질적이고 짜증이 나게 되어 일상생활에 많은 영향을 끼친다. 호흡기는 일차적인 감염의 경로가 된다. 세균과 바이러스 환경오염 등에 의해 발생하는 호흡기성질환이 점진적으로 증가함에 따라 감염체로부터 호흡기를 보호하고 그 질환들을 효과적으로 치유 할 수 있는 약물의 필요성이 있어왔다.The human nose regulates 10,000 to 20,000 liters of air per day, filtering and extinguishing numerous infectious agents, antigens and toxins. The nose is also a very sensitive area, so there are a number of causes that can easily block your nose. In this case, the oxygen supply to the head is not smooth enough to interfere with the brain, nervous and irritable to affect a lot of daily life. The respiratory tract is the primary route of infection. As respiratory diseases caused by bacterial and viral environmental pollution gradually increase, there has been a need for drugs that can effectively protect the respiratory organs from infectious agents and effectively cure the diseases.
팔각(학명: Star anis)은 중국 광서, 광동, 운남 등지에서 널리 사용하는 향신료 겸 한약재로 신종플루에 효과가 있다고 알려진 타미플루의 재료로 사용되며, 트랜스-아네톨(C10H12O), 아니스알데히드(C8H8O7), 사프롤(C10H10O2), 아니식케톤(C10H12O2)의 정유를 함유한다. 주로 음식요리 향료로 이용되어 왔으며, 항암, 항균 효과를 포함하여 여러 약리적 효과가 보고되었다.Octagon (Star anis) is a spice and herbal medicine widely used in Guangxi, Guangdong, Yunnan, China, and is used as a material for Tamiflu, which is known to be effective against swine flu. And essential oils of saprol (C10H10O2) and anisik ketone (C10H12O2). It has been used mainly as a food flavoring agent, and several pharmacological effects, including anticancer and antimicrobial effects, have been reported.
에센셜 오일들이 공통적으로 가지고 있는 여러 가지 의학적인 효과들 중에서 특히 살균 방부효과는 현대인들의 많은 관심을 가지고 있다. 또한 에센셜오일이 갖는 특성이 강한 휘발성을 가지고 있기 때문에 휘발성 냄새입자가 코와 폐를 통해 유입되어 자신이 갖고 있는 산소 분자를 쉽게 증발하여 그 산소 분자를 방출하여 오존과 음이온을 형성 세균, 바이러스, 곰팡이 등이 서식 할 수 없는 깨끗한 환경을 만들어 호흡기를 보호하고 안정화시켜주며, 상쾌함과 머리를 맑게 해 주는 것이다.Among the many medical effects that essential oils have in common, bactericidal preservatives are of particular interest to modern people. In addition, because essential oils have a strong volatility, volatile odor particles flow through the nose and lungs, and easily evaporate oxygen molecules they have and release those oxygen molecules to form ozone and anions bacteria, viruses, and fungi It creates a clean environment in which your back can't live and protects and stabilizes your respiratory tract, as well as refreshing and clearing your head.
향을 발산하는 한약재들로 목향, 당귀, 감국, 창출, 석창포들은 그 효능으로 면역작용, 신경안정과 항균작용이 민들레, 어성초는 항균과 해독작용이 강하고, 호흡기 질환에 탁월한 효과를 가지고 있다고 알려져있다.It is known that Mokyang, Angelica, Gamuk, Creation, and Seokchangpo have the effects of immunity, nerve stability, and antibacterial activity. Dandelion and Echochocho are strong antibacterial and detoxification effects, and have excellent effects on respiratory diseases. .
일반적으로 수많은 항균제나 항생제, 항바이러스제들이 개발되어 왔고 현재도 개발 중에 있다. 이러한 화합물들은 인체에 부작용이나 내성균을 유발한다는 단점도 또한 알려져 있다. 이에 천연물질로의 대체가 필요한 현실이다.In general, a number of antimicrobials, antibiotics and antivirals have been developed and are still under development. It is also known that these compounds cause side effects or resistant bacteria in the human body. This is a reality that needs to be replaced by natural substances.
팔각이나 방향 한약재 그리고 아로마 오일들이 제각각 방향제나 항균제로 사용되고 있으나 그 특성들이 흡입 가능하기에는 특별한 향에 거부감을 느끼거나, 흡 입시 효과가 기대에 못 미치고 있다.Octagonal or aromatic herbal medicines and aroma oils are used as fragrances or antimicrobial agents, respectively, but the characteristics are inhalable, or the effect of inhalation is not as expected.
이에 본 발명자들은 항균 또는 코막힘, 코골이, 비염 등의 비강질환에 효과가 있는 새로운 조성물을 개발하기 위해 연구한 결과, 팔각을 비롯하여 여러가지 방향 한약재 및 천연 아로마 오일을 혼합한 혼합조성물이 우수한 항균 효과 및 비강질환에 효과가 있음을 확인하여 본 발명을 완성하였다.Therefore, the present inventors have studied to develop a new composition that is effective in antibacterial or nasal diseases such as nasal congestion, snoring, and rhinitis. As a result, the mixed composition of various aromatic herbs and natural aromatic oils, including octagons, is excellent. And confirmed that the effect on the nasal disease has completed the present invention.
따라서 본 발명은 상기의 이러한 문제점을 해결하고자 인체에 대한 안정성과 천연의 항균력을 가진 향신류, 한약재, 정유 등의 동서양의 식물 추출물들을 활용, 적절히 배합하여 호흡기에 흡입 사용, 향취만족도를 높이고 그 임상적 효능과 안정성이 동시에 개선되는 최적의 혼합물질 제조를 목적으로 한다.Therefore, the present invention utilizes plant extracts of East and West plants such as spices, herbal medicines, essential oils, etc., having stability against the human body and natural antimicrobial ability to solve the above problems, inhaled in the respiratory use, increase the satisfaction level of the odor and clinically It is aimed at producing optimal mixtures with simultaneous improvement in potency and stability.
상기와 같은 해결하고자 하는 과제를 위하여, 본 발명에 따른 코막힘, 코골이 및 비염으로 이루어진 군에서 선택된 비강질환 예방 및 치료용 조성물은, 팔각 2 내지 4중량부, 감국 6 내지 8중량부, 창출 2 내지 4중량부, 목향 4 내지 6중량부, 당귀 4 내지 6중량부, 석창포 4 내지 6중량부, 어성초 2 내지 4중량부, 민들레 4 내지 6중량부 비율로 혼합하여 추출한 방향 한약재 추출물과; 유칼립투스 오일, 티 트리 오일, 라벤다 오일, 페파민트 오일 및 레몬 오일을 500:200:100:50:200의 부피 비율로 혼합한 아로마오일 혼합물을; 30:1의 중량비로 혼합한 것을 특징으로 한다.For the problem to be solved as described above, the composition for preventing and treating nasal diseases selected from the group consisting of nasal congestion, snoring and rhinitis according to the present invention, octagonal 2 to 4 parts by weight, 6 to 8 parts by weight of the country, creation 2-4 parts by weight, 4-6 parts by weight of Mok Hyang, 4-6 parts by weight of Angelica, 4-6 parts by weight of Seokchangpo, 2-4 parts by weight of Echo vinegar, 4-6 parts by weight of Dandelion, and extract the aromatic herbal medicine extract; An aromatic oil mixture comprising eucalyptus oil, tea tree oil, lavender oil, peppermint oil and lemon oil in a volume ratio of 500: 200: 100: 50: 200; It is characterized by mixing in a weight ratio of 30: 1.
본 발명의 다른 실시예로서, 항균용 조성물은, 팔각 2 내지 4중량부, 감국 6 내지 8중량부, 창출 2 내지 4중량부, 목향 4 내지 6중량부, 당귀 4 내지 6중량부, 석창포 4 내지 6중량부, 어성초 2 내지 4중량부, 민들레 4 내지 6중량부 비율로 혼합하여 추출한 방향 한약재 추출물과; 유칼립투스 오일, 티 트리 오일, 라벤다 오일, 페파민트 오일 및 레몬 오일을 500:200:100:50:200의 부피 비율로 혼합한 아로마오일 혼합물을; 30:1의 중량비로 혼합한 것을 특징으로 한다.As another embodiment of the present invention, the antimicrobial composition is 8 to 8 parts by weight, 8 to 8 parts by weight, 8 to 4 parts by weight, 8 to 4 parts by weight, 4 to 6 parts by weight, 4 to 6 parts by weight, Angelica 4 Aromatic herbs extract extracted by mixing in a ratio of 6 to 6 parts by weight, Eoseongcho 2 to 4 parts by weight, dandelion 4 to 6 parts by weight; An aromatic oil mixture comprising eucalyptus oil, tea tree oil, lavender oil, peppermint oil and lemon oil in a volume ratio of 500: 200: 100: 50: 200; It is characterized by mixing in a weight ratio of 30: 1.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 조성물은 팔각 2 내지 4중량부, 감국 6 내지 8중량부, 창출 2 내지 4중량부, 목향 4 내지 6중량부, 당귀 4 내지 6중량부, 석창포 4 내지 6중량부, 어성초 2 내지 4중량부, 민들레 4 내지 6중량부의 혼합추출물 30중량부 및 유칼립투스 오일 500㎕, 티 트리 오일 200㎕ , 라벤다 오일 100㎕, 페파민트 오일 50㎕, 레몬 오일 200㎕을 포함하는 아로마오일 혼합물 1중량부의 혼합물을 주성분으로 하는 것으로 코막힘, 코골이 및 비염과 같은 비강질환에 효과가 있고, 우수한 항균활성을 가진다.The composition of the present invention is 2 to 4 parts by weight octagonal, 6 to 8 parts by weight of persimmon soup, 2 to 4 parts by weight, 4 to 6 parts by weight of Mokyang, 4 to 6 parts by weight, Angelica 4 to 6 parts by weight, 4 to 6 parts by weight of Seokcho 1 part by weight of an aromatic oil mixture comprising 4 parts by weight, 30 parts by weight of a mixed extract of dandelion 4-6 parts and 500 μl of eucalyptus oil, 200 μl of tea tree oil, 100 μl of lavender oil, 50 μl of peppermint oil, 200 μl of lemon oil The main ingredient of the mixture is effective in nasal diseases such as nasal congestion, snoring and rhinitis, and has excellent antibacterial activity.
본 발명의 조성물은 팔각 등의 방향 한약재 추출물과 아로마오일 혼합액을 30 : 1의 중량비로 혼합하여 제조할 수 있다.The composition of the present invention can be prepared by mixing the aromatic herbal extracts such as octagonal and aroma oil mixed solution in a weight ratio of 30: 1.
본 발명의 조성물 중 한약재 추출물은 당업계에 공지된 용매 추출법에 의해 제조할 수 있다. 예를 들어, 물, 에탄올 및 메탄올과 같은 탄소수 1 내지 6개의 알코올, 아세톤, 에틸아세테이트, n-핵산, 디에틸에테르, 아세톤, 벤젠과 같은 유기용매 중에서 선택된 어느 하나 또는 이들의 혼합용매를 이용하여 추출할 수 있다. 바람직하게는, 물 또는 탄소수 1 내지 6개의 알코올을 사용하여 추출할 수 있다. 상기 용매 추출법에 의해 추출물을 제조하는 경우에는 열수 추출, 초음파 추출 및 환류 추출 방법을 사용할 수 있다. 가장 바람직하게는, 본 발명의 추출물은 물을 용매로 이용하여 열수 추출방법에 의해 제조될 수 있다.Herbal extract of the composition of the present invention can be prepared by a solvent extraction method known in the art. For example, using any one selected from alcohols having 1 to 6 carbon atoms such as water, ethanol and methanol, organic solvents such as acetone, ethyl acetate, n-nucleic acid, diethyl ether, acetone, benzene, or a mixed solvent thereof. Can be extracted. Preferably, the extraction may be performed using water or an alcohol having 1 to 6 carbon atoms. When the extract is prepared by the solvent extraction method, hot water extraction, ultrasonic extraction and reflux extraction may be used. Most preferably, the extract of the present invention may be prepared by a hot water extraction method using water as a solvent.
추출시 온도는 상압 하의 실온에서 수행하는 것이 바람직하며 추출시간은 추출온도에 따라 다르지만, 1시간 내지 6시간, 바람직하게는 2시간 내지 4시간 추출한다. 또한, 추출시 교반기(shaker)로 교반할 경우에 더욱 추출효율을 증대시킬 수 있다.The temperature during extraction is preferably performed at room temperature under atmospheric pressure and the extraction time depends on the extraction temperature, but is extracted from 1 hour to 6 hours, preferably 2 hours to 4 hours. In addition, the extraction efficiency can be further increased when stirring with a shaker (shaker) during extraction.
추출에 사용되는 각각의 한약재는 수확한 후 세척하여 그대로 사용하거나 건조하여 사용할 수 있다. 건조방법으로는 양건, 음건, 열풍건조 및 자연 건조하는 방법을 모두 사용할 수 있다. 또한, 추출효율을 증대시키기 위해 각각의 한약재 또는 그 건체를 분쇄기로 분쇄하여 사용할 수 있다.Each herb used for extraction can be harvested, washed and used as is or dried. As a drying method, both dry, shade, hot air drying and natural drying can be used. In addition, in order to increase the extraction efficiency, each herbal medicine or its dry matter may be used by grinding with a grinder.
본 발명의 조성물에 포함되는 한약재의 바람직한 함량과 효능은 하기 표 1과 같다.Preferred contents and efficacy of the herbal medicine contained in the composition of the present invention are shown in Table 1 below.
본 발명이 조성물에 포함되는 아로마 오일은 유칼립투스 오일 500㎕, 티 트리 오일 200㎕ , 라벤다 오일 100㎕, 페파민트 오일 50㎕, 레몬 오일 200㎕을 포함하는 아로마오일 혼합물일 수 있으며, 각각의 아로마 오일은 추출재료로 부터 당업계에 공지된 오일 추출 방법에 따라 제조되거나, 상용의 것을 사용할 수 있다.The aroma oil included in the composition of the present invention may be an aromatic oil mixture including 500 μl of eucalyptus oil, 200 μl of tea tree oil, 100 μl of lavender oil, 50 μl of peppermint oil, 200 μl of lemon oil, and each of the aroma oils includes From the extracting material, it may be prepared according to an oil extraction method known in the art, or a commercial one may be used.
본 발명의 조성물에 포함되는 아로마오일의 바람직한 함량과 효능은 하기 표 2와 같다.Preferred contents and efficacy of the aromatic oil contained in the composition of the present invention are shown in Table 2 below.
본 발명의 조성물은 비강질환을 예방 또는 치료하는 효과를 가진다. 비강질환은 코막힘, 코골이 또는 비염일 수 있다.The composition of the present invention has the effect of preventing or treating nasal diseases. Nasal diseases may be nasal congestion, snoring or rhinitis.
본 발명의 조성물은 투여 경로에 따라 적합한 담체와 함께 제형화될 수 있다. 바람직하게는 스프레이 제제의 형태의 흡입투여제로 제형화될 수 있다.The composition of the present invention may be formulated with a suitable carrier depending on the route of administration. It may preferably be formulated as an inhalation agent in the form of a spray formulation.
흡입 투여제의 경우, 본 발명의 조성물은 적합한 추진제, 예를 들면, 디클로로플루오로메탄, 트리클로로플루오로메탄, 디클로로테트라플루오로에탄, 이산화탄소 또는 다른 적합한 기체를 사용하여, 가압 팩 또는 연무기로부터 에어로졸 스프레이 형태로 편리하게 전달 할 수 있다. 가압 에어로졸의 경우, 투약 단위는 계량된 양을 전달하는 밸브를 제공하여 결정할 수 있다. 예를 들면, 흡입기 또는 취입기에 사용되는 젤라틴 캡슐 및 카트리지는 화합물, 및 락토즈 또는 전분과 같은 적합한 분말 기제의 분말 혼합물을 함유하도록 제형화할 수 있다.In the case of inhaled dosages, the compositions of the present invention can be used in combination with a suitable propellant, for example, dichlorofluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane, carbon dioxide or other suitable gas, to aerosol from a pressurized pack or nebulizer. It can be delivered conveniently in the form of a spray. In the case of a pressurized aerosol, the dosage unit can be determined by providing a valve to deliver a metered amount. For example, gelatin capsules and cartridges for use in an inhaler or insufflator may be formulated to contain a compound, and a powder mixture of a suitable powder base such as lactose or starch.
그 밖의 약학적으로 허용되는 담체로는 다음의 문헌에 기재되어 있는 것을 참고로 할 수 있다(Remington's Pharmaceutical Sciences, 19th ed., Mack Publishing Company, Easton, PA, 1995).Other pharmaceutically acceptable carriers can be found in Remington's Pharmaceutical Sciences, 19th ed., Mack Publishing Company, Easton, Pa., 1995).
또한, 본 발명에 따른 약학적 조성물은 하나 이상의 완충제(예를 들어, 식염수 또는 PBS), 카보하이트레이트(예를 들어, 글루코스, 만노즈, 슈크로즈 또는 덱스트란), 항산화제, 정균제, 킬레이트화제(예를 들어, EDTA 또는 글루타치온), 아쥬반트(예를 들어, 알루미늄 하이드록사이드), 현탁제, 농후제 및/또는 보존제를 추가로 포함할 수 있다.In addition, the pharmaceutical compositions according to the invention may comprise one or more buffers (e.g. saline or PBS), carbohydrates (e.g. glucose, mannose, sucrose or dextran), antioxidants, bacteriostatic agents, chelating agents (Eg, EDTA or glutathione), adjuvants (eg, aluminum hydroxide), suspending agents, thickening agents, and / or preservatives.
또한, 본 발명의 조성물은 포유동물에 투여된 후 활성 성분의 신속, 지속 또는 지연된 방출을 제공할 수 있도록 당업계에 공지된 방법을 사용하여 제형화될 수 있다.In addition, the compositions of the present invention may be formulated using methods known in the art so as to provide rapid, sustained or delayed release of the active ingredient after administration to the mammal.
따라서, 본 발명의 조성물은 미생물로 부터 호흡기를 보호하고 코막힘과 코콜이 비염의 호흡질환을 호전시키고 머리를 맑게 하는 최적의 항균성 천연 방향 한방아로마 물질로, 본 발명은 팔각과 방향 한방재료들, 아로마오일을 적절히 배합하여 스프레이 등으로 흡입하여 사용함으로서 그 향취로 인한 상쾌함과 함께 항균작용, 코막힘, 코골이, 비염의 각종 호흡질환의 개선으로 효용성이 매우 높다고 하겠다.Therefore, the composition of the present invention is an optimal antimicrobial natural aromatic herbal aroma substance that protects the respiratory organs from microorganisms and prevents nasal congestion and kokol improves respiratory diseases of rhinitis and clears the head. By properly injecting oil and inhaling it with a spray, etc., it is said to be very effective due to the refreshing effect of the odor and antibacterial action, nasal congestion, snoring, and improvement of various respiratory diseases of rhinitis.
이하. 본 발명을 실시예에 의해 상세히 설명한다.Below. The present invention will be described in detail by way of examples.
단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
<실시예 1><Example 1>
천연 한방아로마 혼합액의 제조Preparation of Natural Herbal Aroma Mixtures
팔각 3g, 감국 7g, 창출 3g, 목향 5g, 당귀 5g, 석창포 5g, 어성초 3g, 민들레 5g을 분쇄하여 배합시켜 10시간 동안 상온에 방치하여 우려내고, 다시 30분을 가열하여 걸러내어 한방 전탕액을 제조하였다.Octagonal 3g, Gamuk 7g, Creation 3g, Mokhyang 5g, Angelica 5g, Seokchangpo 5g, Eoseongcho 3g, Dandelion 5g, crushed and blended, left at room temperature for 10 hours to simmer, and heated again for 30 minutes Prepared.
위의 혼합액에 유칼립투스 오일 500㎕, 티 트리 오일 200㎕ , 라벤다 오일 100㎕, 페파민트 오일 50㎕, 레몬 오일 200㎕을 혼합한 아로마오일 혼합액을 첨가하여 본 발명의 조성물을 제조한 다음 이를 스프레이 제제의 형태로 제형화하였다.To prepare a composition of the present invention by adding an aromatic oil mixture of 500 μl of eucalyptus oil, 200 μl of tea tree oil, 100 μl of lavender oil, 50 μl of peppermint oil, and 200 μl of lemon oil, the composition of the present invention was added. Formulated in form.
<실험예 1><Experimental example 1>
시료의 제조와 항균력 흡광도 측정Sample Preparation and Antimicrobial Absorbance Measurement
테스트 튜브에 액체배지 3㎖와 상기의 실시예 1의 조성물을 첨가하여 시료를 만들었다. 시료에 대장균(Escherichia coli)을 접종하여 37℃에서 2일간 배양 후 흡광도를 측정하였다.A sample was prepared by adding 3 ml of the liquid medium and the composition of Example 1 to the test tube. E. coli (Escherichia coli) was inoculated onto the sample and the absorbance was measured after 2 days of incubation at 37 ℃.
그 결과, 표 3에서 보듯이, 본 발명의 조성물이 첨가된 경우 대장균 증식이 억제되어 항균활성을 가짐을 알 수 있었다. 특히 본 발명의 조성물, 즉 천연 한방아로마 혼합액은 항균 효과가 한약재 추출물 혼합액(한방혼합액)과 아로마 오일을 각각 따로 사용했을 때보다 더 우수한 항균 효과가 나타남을 알 수 있었다.As a result, as shown in Table 3, it was found that when the composition of the present invention is added, E. coli proliferation is suppressed to have an antimicrobial activity. In particular, the composition of the present invention, that is, natural herbal aroma mixture solution was found that the antimicrobial effect is better than when using the herbal medicine extract mixture (herbal mixture) and aroma oil separately.
<실험예 2><Experimental example 2>
향취만족도와 임상평가Fragrance Satisfaction and Clinical Evaluation
상기 제조된 천연 한방 아로마 스프레이를 대상으로 평가 인원 10명, 평균연령대 34세 실내온도 20℃조건하에서 스프레이를 이용 코 안에 직접 흡입하여 향취만족도 조사(5점 기준; 점수가 높을 수록 긍정)를 실시하였고 그 결과는 표 4에 나타내었다.For the natural herbal aroma spray prepared above, 10 people were evaluated, and the average age group was 34 years old. Inhalation was carried out directly in the nose using a spray under the condition of 20 ° C. The satisfaction satisfaction survey was conducted (based on 5 points; the higher the score, the more positive). The results are shown in Table 4.
또한 상기 제조된 천연 한방 아로마 스프레이를 코콜이 증상을 가진 남자 인원 10명과 감기로 인한 코막힘을 가진 자원자 10명, 그리고 비염 환자 10명을 대상으로 코 안에 직접 흡입하여 5일간 간이 임상 조사를 실시하였고 그 결과는 표6에 나타내었다(평점 1점 : 전혀 효과 없음; 2점 : 약간의 효과 있음; 3점 : 어느정도 효과 있음; 4점 : 효과가 좋음; 5점 : 아주 효과가 좋음).In addition, the herbal herbal aroma spray prepared above was directly inhaled into the nose of 10 males with symptoms of Cokol, 10 volunteers with nasal congestion, and 10 rhinitis patients. The results are shown in Table 6 (1 point: no effect at all; 2 points: some effects; 3 points: some effects; 4 points: good effects; 5 points: very effective).
그 결과, 상기 표 5에서 보듯이, 본 발명의 조성물이 기분을 상쾌하게 해주고 호흡기 질환에 상당한 효과가 있는 것을 알수있다. 그러므로 나아가 감기나 인플루엔자에도 상당한 효과가 있을 것이라 사료된다.As a result, as shown in Table 5, it can be seen that the composition of the present invention refreshes the mood and has a significant effect on respiratory diseases. Therefore, it is expected to have a significant effect on colds and influenza.
이상 살펴본 바와 같이, 본 발명의 조성물은 미생물로 부터 호흡기를 보호하고 코막힘과 코콜이 비염의 호흡질환을 호전시키고 머리를 맑게 하는 최적의 항균성 천연 방향 한방아로마 물질로, 본 발명은 팔각과 방향 한방재료들, 아로마오일을 적절히 배합하여 스프레이 등으로 흡입하여 사용함으로서 그 향취로 인한 상쾌함과 함께 항균작용, 코막힘, 코골이, 비염의 각종 호흡질환의 개선으로 효용성이 매우 높다고 하겠다.As described above, the composition of the present invention is an optimal antimicrobial natural aromatic herbal aroma material that protects the respiratory organs from microorganisms and prevents nasal congestion and Cocoul's respiratory disease of rhinitis and clears the head. Field, aroma oils by appropriately inhaled by spray, etc., the freshness of the odor and antimicrobial action, nasal congestion, snoring, rhinitis, various respiratory diseases to improve the effectiveness is very high.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090107319A KR101125482B1 (en) | 2009-11-09 | 2009-11-09 | Composition for preventing and treating nose disease comprising extract of Star anis and aroma oil as active ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090107319A KR101125482B1 (en) | 2009-11-09 | 2009-11-09 | Composition for preventing and treating nose disease comprising extract of Star anis and aroma oil as active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110050793A KR20110050793A (en) | 2011-05-17 |
KR101125482B1 true KR101125482B1 (en) | 2012-03-19 |
Family
ID=44361270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090107319A KR101125482B1 (en) | 2009-11-09 | 2009-11-09 | Composition for preventing and treating nose disease comprising extract of Star anis and aroma oil as active ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101125482B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210066267A (en) | 2019-11-28 | 2021-06-07 | (주)아로마용 | Aroma oil serum composition comprising frankincense oil |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102416069A (en) * | 2011-11-16 | 2012-04-18 | 杭州奇炜生物科技有限公司 | Nasal cavity cleaning agent |
CN102488767B (en) * | 2011-12-27 | 2013-12-25 | 张朝晖 | Compound composition for treating bacterial diarrhoea of livestock and poultry |
CN103223019A (en) * | 2013-04-04 | 2013-07-31 | 施怀杰 | Traditional Chinese medicine for treating rhinitis |
CN103816224A (en) * | 2013-12-31 | 2014-05-28 | 广西亿康药业股份有限公司 | Chinese medicine preparation for treating acute and chronic rhinitis and improvement on preparation method thereof |
CN104800374B (en) * | 2015-05-15 | 2018-06-08 | 天津佰力喜动物药业有限公司 | A kind of traditional Chinese medicine oral liquid for treating poultry breathing problem |
CN104873621A (en) * | 2015-05-23 | 2015-09-02 | 周末 | Antibacterial and anti-inflammation traditional Chinese medicine composition |
CN105288564A (en) * | 2015-11-30 | 2016-02-03 | 黄晓 | Foot soaking liquid for curing typhoid fever, cold and rhinobyon |
RU2616523C1 (en) * | 2016-05-27 | 2017-04-17 | Отия Варламович Сичинава | Intranasal ointment for treatment and prevention of respiratory infection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060015821A (en) * | 2004-08-16 | 2006-02-21 | 이종노 | Medicine for treating nasitis including herb |
KR20060112831A (en) * | 2005-04-28 | 2006-11-02 | 김중길 | Noble fragrance composition comprising aroma oil with excellent maintainance of air cleaning and preparation thereof |
-
2009
- 2009-11-09 KR KR1020090107319A patent/KR101125482B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060015821A (en) * | 2004-08-16 | 2006-02-21 | 이종노 | Medicine for treating nasitis including herb |
KR20060112831A (en) * | 2005-04-28 | 2006-11-02 | 김중길 | Noble fragrance composition comprising aroma oil with excellent maintainance of air cleaning and preparation thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210066267A (en) | 2019-11-28 | 2021-06-07 | (주)아로마용 | Aroma oil serum composition comprising frankincense oil |
Also Published As
Publication number | Publication date |
---|---|
KR20110050793A (en) | 2011-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101125482B1 (en) | Composition for preventing and treating nose disease comprising extract of Star anis and aroma oil as active ingredients | |
WO2021218945A1 (en) | Antibacterial antiviral pharmaceutical composition and application thereof | |
Horváth et al. | Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti‐inflammatory action: a review | |
CN1287671C (en) | Mosquito killing disinfectant | |
CN101485647B (en) | Use of patchouli alcohol in preparing medicament | |
CN101391108B (en) | Traditional Chinese medicine air fresh bacteriostat and preparation method thereof | |
WO2014023145A1 (en) | Mite killing bactericide and method for preparing same | |
CN106538638A (en) | A kind of Chinese medicine antiseptic and preparation method thereof | |
CN103585540B (en) | Incense-fumigating oil of rhizoma atractylodis and folium artemisiae argyi | |
CN105340998A (en) | Natural traditional Chinese medicine mosquito-repellent incense and preparation method thereof | |
CN102428972A (en) | Liquidd mosquito-repellent incense made of folium artemisiae argyi and preparation method thereof | |
CN106336721A (en) | Compound active mineral environmental-protection ink | |
KR20030019097A (en) | Compositions for treatment and prevention of cold having antiviral activity | |
CN104758322A (en) | Composition capable of expelling insects, killing bacteria, sterilizing, and relieving nerve, and applications thereof | |
CN103263679A (en) | Drug-smelling plant air clean fluid for purifying environment and reinforcing respiratory system | |
WO2008074028A1 (en) | Methods for treating and reducing the incidence of newcastle disease | |
CN114028435A (en) | Atomized liquid containing cordyceps militaris extract and application thereof | |
CN112704697A (en) | Atomized liquid for resisting epidemic and maintaining respiratory tract health and preparation method thereof | |
CN113749129A (en) | Air freshener and insect repellent liquid and preparation method thereof | |
EP1294373A1 (en) | Pharmaceutical disinfectants comprising usnic acid and essential oils | |
Al-Harrasi et al. | Essential Oils in the Treatment of Respiratory Tract Infections | |
Sainhi et al. | A Review Article on Phytochemicals New Line of Treatment of Sars Covid-19 | |
JP2010517956A (en) | Citus extract (Cistus Extracts) | |
CN111135211A (en) | Preparation of tea tree essential oil inclusion compound and gasification inhalation type administration method thereof | |
CN104888260A (en) | Traditional Mongolian and Chinese medicine air freshener for realizing insect expelling and sterilization of muniment room |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20141225 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160225 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170302 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180226 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190919 Year of fee payment: 8 |
|
R401 | Registration of restoration |